Looming Tariffs Don't Scare This Swiss Cancer Treatment Stock

investors.com/research/cancer-treatment-beone-medicines-onc-stock-jnj/?src=A00220

Switzerland-based cancer treatment developer BeOne Medicines (ONC) is having a good week. Its stock has climbed nearly 11% so far over the last three sessions. Several factors may be boosting the biotech stock. The IBD 50 Growth Stocks To Watch pick for Wednesday may be rising in…

This story appeared on investors.com, 2025-07-16 16:57:28.
The Entire Business World on a Single Page. Free to Use →